Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, an inactivated hepatitis A vaccine; bilive, a combined inactivated hepatitis A and B vaccine; anflu, a split viron influenza vaccine; panflu, a vaccine against the H5N1 influenza and inlive, an enterovirus type 71 vaccine. Sinovac Biotech also developed panflu.1, a vaccine against the influenza A H1N1 virus. The company conducts research to develop novel vaccines for infectious diseases including SARS, avian influenza, H1N1 influenza and hand foot and mouth disease. The company markets its products across China and abroad. Sinovac Biotech is headquartered in Beijing, China.
Headquarters
China
Address
No. 39 Shangdi Xi Road, Haidian District, Beijing, 100085
Website
www.sinovac.com
Telephone
86 10 82890088
No of Employees
3,558
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
SVA (NASD)
Revenue (2021)
$1.5B
-92.3%
(2021 vs 2020)
EPS
XYZ
Net Income (2021)
XYZ
-98.7%
(2021 vs 2020)
Market Cap*
$639.9M
Net Profit Margin (2021)
XYZ
-82.5%
(2021 vs 2020)
* As of and is in US$
Sinovac Biotech Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Hepatitis A and B Vaccine | Logistics Distribution | Healive |
| Hand-Foot-Month Disease (HFMD) Vaccine | Phone Consultation | Anflu |
| H1N1 Influenza A Vaccine | Panflu | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Sinovac Biotech Ltd | China National Accord Medicines Corporation Ltd | Beijing Tiantan Biological Products Co Ltd | CanSino Biologics Inc | Beijing Tri-Prime Genetic Engineering Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Beijing | Shenzhen | Beijing | Tianjin | Beijing |
| State/Province | Beijing | Guangdong | Beijing | Tianjin | Beijing |
| No. of Employees | 3,558 | 39,449 | 4,858 | 1,494 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Weidong Yin | Chairman; Chief Executive Officer; President | Executive Board | 2003 | - |
| Nan Wang | Chief Financial Officer; Vice President | Senior Management | 2013 | - |
| Qiang Gao | Chief Operating Officer; Vice President | Senior Management | 2020 | - |
| Guang Yang | Chief Business Officer | Senior Management | - | - |
| Jing Li | Vice President | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer